Poultry Vaccine Market Growth, Size, Share, Trends, and Forecast 2032

Poultry Vaccine Market Industry Prospective

The global Poultry Vaccine Market size was valued at USD 1314.81 Million in 2023 and is predicted to reach USD 2458.19 Million by the end of 2032. The market is expected to grow with a CAGR of 7.2% during the forecast period. The report analyzes the global Poultry Vaccine Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Poultry Vaccine industry.

Request Free Sample

Poultry Vaccine Market Overview

The report covers forecasts and analyses for the poultry vaccine market on a global and regional level. The study highlights historic data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the poultry vaccine market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities and various trends in the poultry vaccine market on a global level.

Request Free Sample

To know more about this report, request a sample copy.

Poultry Vaccine Market: Growth Drivers

Poultry vaccines play an important role in maintaining the health of poultry flocks. Vaccines produce antibodies that allow birds for fighting against invading unexpected organisms. Global demand for the poultry vaccine market is expected to be driven by the growing prevalence of animal diseases, growing outbreaks of poultry diseases, and growth in the poultry population. Also advancements in vaccine technologies and increasing poultry healthcare expenditure further contribute to the growth of the market.

Moreover rising demand for chicken due to the increase in hotel industries all over the globe, growing awareness among people regarding poultry vaccines, and increasing cases of zoonotic diseases are some factors that are fueling the global poultry vaccine market.

Also, various vaccine programs implemented by leading players and various initiatives by the government will further drive the market for the given forecast period. However, increasing maintenance costs for the vaccines, growing demand for vegetarian food, and unaffordability of veterinary services in developed, as well as underdeveloped regions, are some factors that will hinder the growth of the poultry vaccine market.

Poultry Vaccine Market: Segmentation Analysis

Based on diseases, the market is segmented into Marek’s disease, infectious bronchitis, new castle disease, and others. Among the diseased segment, infectious bronchitis dominated the segment. As infectious bronchitis is a highly contagious respiratory disease it spreads among other chickens very easily. The growing poultry population and rapidity in the spread of disease are some factors that are driving this segment.

Based on technology, the market is segmented into recombinant, toxoid, inactivated and live attenuated vaccines (LAV). Among them, live attenuated vaccines dominated the market. The main reason for live attenuated vaccines segment dominance is that it is a low cost technology, used for oral administration, and have long lasting effect.

Based on dosage form, the segment is bifurcated into liquid, duct, and freeze dried vaccines. Among them, freeze dried vaccines dominated the market. Most of the poultries are installed in farms having high temperature. Hence, veterinary doctors recommend freeze dried vaccines more than its counterparts. They have high product life cycle and are easy to store.

Poultry Vaccine Market: Report Scope

North America dominated the global poultry vaccine market in 2018 due to high presence of prominent players who are technologically upgraded and are using high marketing strategies. Growing awareness among people regarding prevention of animal to human transmission diseases, growing demand for chicken due to increasing hotel industries, significant rise of investments in research and development by the companies are some factors which are driving the North America poultry vaccines market.

Rising ownership of poultry birds and availability of insurances are other factors supporting the North American market. Europe was second largest poultry vaccine market in 2018 globally. Government support for research and development in poultry vaccine market, increase in consumable disposable income, and increase in population of non-veg eaters fuels the market growth. Advancement in vaccine technology and increasing role of distribution channels will further contribute to the growth of market. Asia Pacific is estimated to be growing at the highest CAGR over the forecast period. This high growth is due to growing demand for eggs and meat from emerging economies like China and India in this region.

Key Market Players & Competitive Landscape and Segments

Some of the key players in poultry vaccine market are

• Zoetis Inc.
• Phibro Animal Health Corporation
• Virbac
• Venkys
• Biovet
• Anicon GmbH
• Ceva Animal Health Inc
• Elanco
• MSD & Co.
• and Boehringer Ingelheim among others.

Global Poultry Vaccine Market: Disease Type Segments

• Marek’s disease
• Infectious bronchitis
• New castle disease
• Other

Global Poultry Vaccine Market: Technology Segments

• Recombinant
• Toxoid
• Inactivated
• Live attenuated vaccines (LAV)

Global Poultry Vaccine Market: Dosage form Segments

• Liquid
• Duct
• Freeze dried vaccines

Global Poultry Vaccine Market: Region wise Segments 

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa